RxDoctor Payments DataLook up a doctor →

Ki Chung, MD

Hematology & Oncology · Spartanburg, SCNPI 1336110113

Payments from drug & device makers

$4,721,030in general payments, 2019–2025

Across 888 payments — averaging $5316.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Ipsen Biopharmaceuticals, Inc$2M
  • Pfizer$1.1M
  • Epizyme, Inc.$634K
  • AbbVie$130K
  • Seagen Inc.$124K
  • Bayer$116K
  • plus $601K from 54 others
$44in research payments, 2019–2025

Across 1 payment — averaging $44.41 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Taiho Oncology, Inc.$44

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Ipsen Biopharmaceuticals, Inc9$2,003,602
Pfizer86$1,112,684
Epizyme, Inc.3$633,500
AbbVie36$129,878
Seagen Inc.52$124,446
Bayer21$115,750
AstraZeneca(2 entities)44$110,863
Daiichi Sankyo Company LTD6$67,537
Ipsen Bioscience Inc.26$56,187
Daiichi Sankyo Inc.24$55,495
Coherus Oncology, Inc.4$49,224
Takeda Pharmaceuticals U.S.A., Inc.10$48,451
GSK18$45,443
Biontech SE33$41,792
Incyte Corporation92$33,740
Taiho Oncology, Inc.10$22,839
Veloxis Pharmaceuticals, Inc.1$17,580
Astrazeneca UK Limited6$17,440
Genentech USA, Inc.12$5,729
Boehringer Ingelheim Pharma GmbH & Co.kg17$4,849
E.r. Squibb & Sons, L.L.C.29$4,817
Springworks Therapeutics, Inc.7$2,893
Novartis53$2,089
Jazz Pharmaceuticals Inc.3$1,922
Tempus AI, Inc1$1,500
Astellas Pharma Global Development1$1,246
Johnson & Johnson(2 entities)36$988
Merck33$958
Gilead(2 entities)15$763
Exelixis Inc.17$535
Astellas Pharma US Inc14$435
Eisai Inc.20$422
Lilly USA, LLC17$391
Bristol Myers Squibb20$379
Galvanize Therapeutics, Inc2$366
Boehringer Ingelheim International GmbH1$326
Sanofi3$321
Beigene USA, Inc.8$302
Pharmacyclics LLC, An Abbvie Company3$230
Rigel Pharmaceuticals, Inc.6$222
Karyopharm Therapeutics Inc.6$207
Amgen6$195
Stemline Therapeutics Inc.4$194
Mirati Therapeutics, Inc.3$161
Foundation Medicine, Inc.3$154
Genmab U.S., Inc.2$148
Boston Scientific2$148
Pharmacosmos Therapeutics Inc.7$133
Beone Medicines USA, Inc.1$125
Myovant Sciences Inc.1$125
Regeneron Healthcare Solutions, Inc.4$108
AVEO Pharmaceuticals, Inc.1$96
Puma Biotechnology, Inc.1$94
Array Biopharma Inc4$88
Blueprint Medicines Corporation2$86
Sobi, Inc5$82
Tersera Therapeutics LLC4$75
Caris MPI, Inc.2$65
Tolmar, Inc.2$56
ADC Therapeutics America, Inc.3$53

How this compares

$4,721,030 in reported general payments places this provider in the 95th percentile of 166 hematology & oncology providers in South Carolina.

See all hematology & oncology providers in South Carolina →

Medicare billing

Part B allowed, 2024
$141,780
Medicare patients
303
Services billed
2,050

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology & oncology in Spartanburg

See the full list for South Carolina →

Where these figures come from

Is this you, or does something look wrong? →